Lisinopril Tablet
Product Images NDC 51655-994

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 51655-994). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril (133b3fec 07f6 41f5 9c7c 50b66c4c0677 01)

Chemical structure of lisinopril showing its molecular arrangement with labeled atoms and functional groups, including carboxyl (COOH) groups and water of hydration (2H2O). The diagram illustrates the structure of the active pharmaceutical ingredient lisinopril.*

FDA Label Image

Label (51655 994 52 Master Bottle Label Approval Rev A 06 22)

Label for Lisinopril Tablets USP 20 mg, an oral tablet product by Northwind Health Company, LLC. The package includes 30 tablets, marked Rx only. Storage instructions include keeping the product at 20°-25°C, protecting from moisture, freezing, and excessive heat, and storing in the original container. Additional label details such as NDC code 51655-994-52 and batch information are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.